EE200000186A - Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakend - Google Patents
Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakendInfo
- Publication number
- EE200000186A EE200000186A EEP200000186A EEP200000186A EE200000186A EE 200000186 A EE200000186 A EE 200000186A EE P200000186 A EEP200000186 A EE P200000186A EE P200000186 A EEP200000186 A EE P200000186A EE 200000186 A EE200000186 A EE 200000186A
- Authority
- EE
- Estonia
- Prior art keywords
- pharmaceutical
- particle
- preparing
- particles
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97203407 | 1997-11-03 | ||
| PCT/EP1998/006998 WO1999022738A1 (fr) | 1997-11-03 | 1998-10-27 | Compositions d'hypolipemiants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200000186A true EE200000186A (et) | 2001-04-16 |
Family
ID=8228898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000186A EE200000186A (et) | 1997-11-03 | 1998-10-27 | Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakend |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6342245B1 (fr) |
| EP (1) | EP1028730B1 (fr) |
| JP (1) | JP2001521899A (fr) |
| KR (2) | KR20010023729A (fr) |
| CN (1) | CN1278175A (fr) |
| AR (1) | AR013739A1 (fr) |
| AT (1) | ATE216238T1 (fr) |
| AU (1) | AU746890B2 (fr) |
| BG (1) | BG104338A (fr) |
| BR (1) | BR9814109A (fr) |
| CA (1) | CA2307097A1 (fr) |
| DE (1) | DE69804994D1 (fr) |
| EE (1) | EE200000186A (fr) |
| HU (1) | HUP0004139A3 (fr) |
| NO (1) | NO20002279L (fr) |
| NZ (1) | NZ503413A (fr) |
| PL (1) | PL340305A1 (fr) |
| SK (1) | SK5972000A3 (fr) |
| WO (1) | WO1999022738A1 (fr) |
| ZA (1) | ZA989997B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2450957A1 (fr) | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Compositions pharmaceutiques de dispersions de medicaments et de polymeres neutres |
| US20030059487A1 (en) * | 2001-09-21 | 2003-03-27 | Niazi Sarfaraz K. | Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals |
| US20040220240A1 (en) * | 2001-11-28 | 2004-11-04 | Pellegrini Cara A. | Method of increasing the extent of absorption of tizanidine |
| US6455557B1 (en) | 2001-11-28 | 2002-09-24 | Elan Pharmaceuticals, Inc. | Method of reducing somnolence in patients treated with tizanidine |
| JP4919801B2 (ja) * | 2003-09-26 | 2012-04-18 | アルザ・コーポレーシヨン | 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法 |
| KR20120106757A (ko) * | 2003-09-26 | 2012-09-26 | 알자 코포레이션 | 오피오이드 및 비오피오이드 진통제의 제어 방출 제제 |
| NZ546183A (en) * | 2003-09-26 | 2011-04-29 | Alza Corp | Controlled release formulations exhibiting an ascending rate of release |
| EP1663145B1 (fr) * | 2003-09-26 | 2011-04-06 | ALZA Corporation | Baton poussoir oros pour l'administration controlee d'agents actifs |
| DK1683524T3 (da) | 2003-11-14 | 2011-03-14 | Ajinomoto Kk | Dispergering på fast form eller medicinsk præparat på fast form af phenyalaninderivat |
| AU2005230397B2 (en) * | 2004-04-09 | 2010-04-08 | Elanco Animal Health Ireland Limited | Intermittent dosing regimen for the treatment of overweight with MTP-inhibitors |
| WO2005117834A1 (fr) * | 2004-05-27 | 2005-12-15 | Janssen Pharmaceutica N.V. | Dispersions solides d'un compose medicamenteux basique et d'un polymere renfermant des groupes acides |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| KR100582347B1 (ko) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
| WO2006129193A2 (fr) * | 2005-05-27 | 2006-12-07 | Pfizer Products Inc. | Polytherapie pour le traitement de l'obesite ou le maintien du poids apres une perte ponderale |
| JP2009504590A (ja) * | 2005-08-08 | 2009-02-05 | アボット ゲーエムベーハー ウント コンパニー カーゲー | 改善された生物学的利用能をもつ剤型 |
| EP1938804A1 (fr) * | 2006-12-22 | 2008-07-02 | Novartis AG | Préparation pharmaceutique comprenant un antagoniste de neurokinine |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| WO2010143199A1 (fr) | 2009-06-11 | 2010-12-16 | Suven Nishtaa Pharma Private Limited | Dispersion lipidique solide destinée à améliorer la solubilité aqueuse de médicaments peu solubles dans l'eau |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5521186A (en) * | 1994-10-27 | 1996-05-28 | Janssen Pharmaceutica N.V. | Apolipoprotein-β synthesis inhibitors |
| BR9509436A (pt) * | 1994-10-27 | 1998-01-06 | Janssen Pharmaceutica Nv | Inibidores de síntese de apoliproteina-B |
-
1998
- 1998-10-27 US US09/530,170 patent/US6342245B1/en not_active Expired - Fee Related
- 1998-10-27 AU AU11576/99A patent/AU746890B2/en not_active Ceased
- 1998-10-27 NZ NZ503413A patent/NZ503413A/en unknown
- 1998-10-27 HU HU0004139A patent/HUP0004139A3/hu unknown
- 1998-10-27 KR KR1020007002383A patent/KR20010023729A/ko active Search and Examination
- 1998-10-27 BR BR9814109-0A patent/BR9814109A/pt not_active IP Right Cessation
- 1998-10-27 EE EEP200000186A patent/EE200000186A/xx unknown
- 1998-10-27 PL PL98340305A patent/PL340305A1/xx unknown
- 1998-10-27 JP JP2000518671A patent/JP2001521899A/ja not_active Withdrawn
- 1998-10-27 CN CN98810808A patent/CN1278175A/zh active Pending
- 1998-10-27 EP EP98954483A patent/EP1028730B1/fr not_active Expired - Lifetime
- 1998-10-27 AT AT98954483T patent/ATE216238T1/de not_active IP Right Cessation
- 1998-10-27 DE DE69804994T patent/DE69804994D1/de not_active Expired - Lifetime
- 1998-10-27 WO PCT/EP1998/006998 patent/WO1999022738A1/fr not_active Application Discontinuation
- 1998-10-27 SK SK597-2000A patent/SK5972000A3/sk unknown
- 1998-10-27 CA CA002307097A patent/CA2307097A1/fr not_active Abandoned
- 1998-10-27 KR KR1020007002314A patent/KR20010023661A/ko not_active Application Discontinuation
- 1998-11-02 ZA ZA9809997A patent/ZA989997B/xx unknown
- 1998-11-02 AR ARP980105502A patent/AR013739A1/es not_active Application Discontinuation
-
2000
- 2000-04-14 BG BG104338A patent/BG104338A/xx unknown
- 2000-04-28 NO NO20002279A patent/NO20002279L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR013739A1 (es) | 2001-01-10 |
| HUP0004139A2 (hu) | 2002-02-28 |
| NO20002279D0 (no) | 2000-04-28 |
| US6342245B1 (en) | 2002-01-29 |
| AU746890B2 (en) | 2002-05-02 |
| CN1278175A (zh) | 2000-12-27 |
| NZ503413A (en) | 2001-06-29 |
| WO1999022738A1 (fr) | 1999-05-14 |
| AU1157699A (en) | 1999-05-24 |
| EP1028730A1 (fr) | 2000-08-23 |
| EP1028730B1 (fr) | 2002-04-17 |
| BR9814109A (pt) | 2000-10-03 |
| PL340305A1 (en) | 2001-01-29 |
| NO20002279L (no) | 2000-04-28 |
| SK5972000A3 (en) | 2000-12-11 |
| KR20010023729A (ko) | 2001-03-26 |
| CA2307097A1 (fr) | 1999-05-14 |
| ZA989997B (en) | 2000-05-02 |
| JP2001521899A (ja) | 2001-11-13 |
| BG104338A (en) | 2000-12-29 |
| HUP0004139A3 (en) | 2002-03-28 |
| DE69804994D1 (de) | 2002-05-23 |
| KR20010023661A (ko) | 2001-03-26 |
| ATE216238T1 (de) | 2002-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE03902B1 (et) | Osakesed, nende valmistamismeetod ja kasutamine, farmatseutiline doseerimisvorm ja selle valmistamismeetod, tahke dispersioon ning farmatseutiline pakend | |
| EE200000186A (et) | Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakend | |
| EE04991B1 (et) | Osake, ravimvorm, nende valmistamismeetodid, osakeste kasutamine ning farmatseutiline pakend | |
| EE04996B1 (et) | Reguleeritud vabanemisega galantamiinipreparaat, meetod selle valmistamiseks, seda sisaldav doseerimisvorm ning farmatseutiline pakend | |
| EE9900296A (et) | Suure bioomastatavusega fenofibraatide ravimkoostis ja meetod selle valmistamiseks | |
| AU5936400A (en) | Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same | |
| WO2002043702A3 (fr) | Compositions pharmaceutiques pour inhalation | |
| HUP0003990A3 (en) | Methods of treating capsules and dry, powdered pharmaceutical formulations | |
| IL143580A0 (en) | Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof | |
| HUP0100562A3 (en) | Spheroids method for their preparation and pharmaceutical compositions containing them | |
| IL116674A (en) | Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof | |
| HUP0100266A3 (en) | 1-amino-alkylcyclohexane nmda receptor antagonists, pharmaceutical compositions containing the compounds and their preparations | |
| HUP0004024A3 (en) | Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof | |
| AU1606600A (en) | Apparatus and method for desiccating and deagglomerating wet, particulate materials | |
| HUP0104687A3 (en) | Methods for preparing coated drug particles and pharmaceutical formulations thereof | |
| HUP0200309A3 (en) | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them | |
| EE03552B1 (et) | Tahke doseerimisvorm, selle valmistamismeetod, seda sisaldav produkt, tablett ja farmatseutiline pakend ning tsisapriidisoolade kasutamine | |
| HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
| AU1307399A (en) | Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same | |
| HUP0002300A3 (en) | Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
| EE04119B1 (et) | Külmkuivatamiseks sobiv ravimkoostis ja selle valmistamise meetod | |
| EE200300153A (et) | Östrogeeni retseptori modulaatorid, farmatseutiline kompositsioon ja selle valmistamismeetod | |
| AU7201298A (en) | Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it | |
| FI956278A (fi) | Substituoituja 4-fenyylitiatsolijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
| AU5103196A (en) | Form of administration for applying pharmaceutical substances and auxiliary substances, and process for the preparation thereof |